Literature DB >> 25315652

MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism.

Siddhesh Aras1, Minbo Bai1, Icksoo Lee2, Roger Springett3, Maik Hüttemann4, Lawrence I Grossman5.   

Abstract

Our understanding of stress-associated regulatory mechanisms for mitochondria remains incomplete. We now report a new regulator of mitochondrial metabolism, the coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (CHCHD2) which, based on the functionality described here, is renamed MNRR1 (Mitochondria Nuclear Retrograde Regulator 1). It functions in a novel way by acting in two cellular compartments, mitochondria and nucleus. In normally growing cells most MNRR1 is located in mitochondria; during stress most MNRR1 is now located in the nucleus. MNRR1 is imported to the mitochondrial intermembrane space by a Mia40-mediated pathway, where it binds to cytochrome c oxidase (COX). This association is required for full COX activity. Decreased MNRR1 levels produce widespread dysfunction including reduced COX activity, membrane potential, and growth rate, and increased reactive oxygen species and mitochondrial fragmentation. In the nucleus, MNRR1 acts as a transcription factor, one of whose targets is the COX subunit 4 isoform, COX4I2, which is transcriptionally stimulated by hypoxia. This MNRR1-mediated stress response may provide an important survival mechanism for cells under conditions of oxidative or hypoxic stress, both in the acute phase by altering mitochondrial oxygen utilization and in the chronic phase by promoting COX remodeling.
Copyright © 2014 © Elsevier B.V. and Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COX4I2; Hypoxia; Mitochondria; Stress

Mesh:

Substances:

Year:  2014        PMID: 25315652     DOI: 10.1016/j.mito.2014.10.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  51 in total

Review 1.  Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.

Authors:  Zhi-Dong Zhou; Wuan-Ting Saw; Eng-King Tan
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

2.  Sub-mitochondrial localization of the genetic-tagged mitochondrial intermembrane space-bridging components Mic19, Mic60 and Sam50.

Authors:  Mira Sastri; Manjula Darshi; Mason Mackey; Ranjan Ramachandra; Saeyeon Ju; Sebastien Phan; Stephen Adams; Kathryn Stein; Christopher R Douglas; Jiwan John Kim; Mark H Ellisman; Susan S Taylor; Guy A Perkins
Journal:  J Cell Sci       Date:  2017-08-14       Impact factor: 5.285

3.  Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.

Authors:  Isabella R Straub; Alexandre Janer; Woranontee Weraarpachai; Lorne Zinman; Janice Robertson; Ekaterina Rogaeva; Eric A Shoubridge
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

Review 4.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

5.  The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.

Authors:  Neeraja Purandare; Mallika Somayajulu; Maik Hüttemann; Lawrence I Grossman; Siddhesh Aras
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

6.  In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.

Authors:  S R Burstein; F Valsecchi; H Kawamata; M Bourens; R Zeng; A Zuberi; T A Milner; S M Cloonan; C Lutz; A Barrientos; G Manfredi
Journal:  Hum Mol Genet       Date:  2018-01-01       Impact factor: 6.150

7.  CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.

Authors:  Xiaoping Huang; Beverly P Wu; Diana Nguyen; Yi-Ting Liu; Melika Marani; Jürgen Hench; Paule Bénit; Vera Kozjak-Pavlovic; Pierre Rustin; Stephan Frank; Derek P Narendra
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

8.  Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders.

Authors:  Kotaro Ogaki; Shunsuke Koga; Michael G Heckman; Fabienne C Fiesel; Maya Ando; Catherine Labbé; Oswaldo Lorenzo-Betancor; Elisabeth L Moussaud-Lamodière; Alexandra I Soto-Ortolaza; Ronald L Walton; Audrey J Strongosky; Ryan J Uitti; Allan McCarthy; Timothy Lynch; Joanna Siuda; Grzegorz Opala; Monika Rudzinska; Anna Krygowska-Wajs; Maria Barcikowska; Krzysztof Czyzewski; Andreas Puschmann; Kenya Nishioka; Manabu Funayama; Nobutaka Hattori; Joseph E Parisi; Ronald C Petersen; Neill R Graff-Radford; Bradley F Boeve; Wolfdieter Springer; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross
Journal:  Neurology       Date:  2015-11-11       Impact factor: 9.910

Review 9.  Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.

Authors:  Dominik Haddad; Ken Nakamura
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

10.  [Value of CHCHD2 as a potential marker of non-small cell lung cancer: analysis of 60 cases].

Authors:  Rui Xu; Sheng-Yu Wang; Li Wang; Man-Xiang Li; Yang Yao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.